Cargando…

Hospital Admission Patterns in Adult Patients with Community-Acquired Pneumonia Who Received Ceftriaxone and a Macrolide by Disease Severity across United States Hospitals

(1) Objective: There are limited data regarding community-acquired pneumonia (CAP) admissions patterns in US hospitals. Current expert CAP guidelines advocate for outpatient treatment or an abbreviated hospital stay for CAP patients in pneumonia severity index (PSI) risk classes I–III (low risk); ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lodise, Thomas P., Van Le, Hoa, LaPensee, Kenneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557926/ https://www.ncbi.nlm.nih.gov/pubmed/32899697 http://dx.doi.org/10.3390/antibiotics9090577

Ejemplares similares

1462. Hospital Admission Patterns in Adult Patients with Community-Acquired Bacterial Pneumonia Who Received Ceftriaxone and a Macrolide by Pneumonia Severity Index Score
por: Lodise, Thomas, et al.
Publicado: (2018)

Decision Analysis: Omadacycline Relative to Moxifloxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difficile Infection
por: Lodise, Thomas P., et al.
Publicado: (2021)

Correction to: Decision Analysis: Omadacycline Relative to Moxifoxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difcile Infection
por: Lodise, Thomas P., et al.
Publicado: (2021)

Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial
por: Chitra, Surya, et al.
Publicado: (2021)

Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials
por: Lodise, Thomas, et al.
Publicado: (2020)

2197. Ceftriaxone Monotherapy vs. Ceftriaxone Plus Azithromycin for the Treatment of Community-Acquired Pneumonia in Hospitalized, Non-ICU Patients
por: Murter, Forrest, et al.
Publicado: (2019)

1683. Hospital Admission Patterns in Adult Patients with Complicated Urinary Tract Infections (cUTIs): Identification of Potentially Avoidable Hospital Admissions Across United States (US) Hospitals
por: Lodise, Thomas, et al.
Publicado: (2020)

Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial
por: Hamao, Nobuyoshi, et al.
Publicado: (2020)

812 Macrolide Use and Innate Immunity Components in Hospitalized Patients with Community-Acquired Pneumonia
por: Arnold, Forest W., et al.
Publicado: (2014)

Analysis of a Prescription Drug Prior Authorization Program in a Medicaid Health Maintenance Organization
por: LaPensee, Kenneth
Publicado: (2003)

A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant S. pneumoniae in Ambulatory and Hospitalized Adult Patients in the United States
por: Gupta, Vikas, et al.
Publicado: (2021)

Emergence of Macrolide-Resistant Mycoplasma pneumoniae during an Outbreak in a Primary School: Clinical Characterization of Hospitalized Children
por: Hubert, Daniel, et al.
Publicado: (2021)

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2012)

Macrolides and community-acquired pneumonia: is quorum sensing the key?
por: Wise, Matt P, et al.
Publicado: (2010)

Beta-Lactam Plus Macrolide for Patients Hospitalized With Community-Acquired Pneumonia: Difference Between Autumn and Spring
por: Kim, Yoonjung, et al.
Publicado: (2022)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
por: Chen, Yu-Chin, et al.
Publicado: (2020)

1463. Comparative Evaluation of Adverse Tendon Events Between Recipients of Fluoroquinolones and Ceftriaxone/Azithromycin Among Veterans Affairs Patients with Community Acquired Bacterial Pneumonia
por: Patel, Nimish, et al.
Publicado: (2018)

The In Vitro Efficacy of Activated Charcoal in Fecal Ceftriaxone Adsorption among Patients Who Received Intravenous Ceftriaxone
por: Torvorapanit, Pattama, et al.
Publicado: (2023)

A Prediction Tool for the Presence of Ceftriaxone-Resistant Uropathogens upon Hospital Admission
por: Li, Nancy Yanzhe, et al.
Publicado: (2020)

Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae
por: Komatsu, Haruki, et al.
Publicado: (2014)

The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae
por: Yayan, Josef
Publicado: (2014)

First Description of Macrolide-Resistant Mycoplasma pneumoniae in Adults with Community-Acquired Pneumonia in Italy
por: Loconsole, Daniela, et al.
Publicado: (2019)

Lack of pathogen identification influencing antibiotic de-escalation in hospital-acquired pneumonia
por: Bittmann, Matthew C., et al.
Publicado: (2022)

In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia
por: Grijalva, Carlos G., et al.
Publicado: (2015)

Respiratory Fluoroquinolones Monotherapy vs. β-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis
por: Liu, Sitong, et al.
Publicado: (2019)

Hospital admissions among people who inject opioids following syringe services program implementation
por: Bornstein, K. J., et al.
Publicado: (2020)

Clinical Benefits of Piperacillin/Tazobactam versus a Combination of Ceftriaxone and Clindamycin in the Treatment of Early, Non-Ventilator, Hospital-Acquired Pneumonia in a Community-Based Hospital
por: Park, Ga Eun, et al.
Publicado: (2020)

Impact of Intrapartum Oral Azithromycin on the Acquired Macrolide Resistome of Infants’ Nasopharynx: A Randomized Controlled Trial
por: Bojang, Abdoulie, et al.
Publicado: (2020)

Inter-hospital variation in the utilization of diagnostics and their proportionality in the management of adult community-acquired pneumonia
por: Vestjens, Stefan M. T., et al.
Publicado: (2018)

Etiology and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia
por: Nolan, Vikki G, et al.
Publicado: (2018)

Impact of Obesity on Ceftriaxone Efficacy †
por: Barber, Katie E., et al.
Publicado: (2020)

Genotyping and macrolide resistance of Mycoplasma pneumoniae identified in children with community-acquired pneumonia in Medellín, Colombia
por: Copete, Angela Rocio, et al.
Publicado: (2018)

Hospital-acquired Hyponatremia in Pediatric Intensive Care Unit
por: Sachdev, Anil, et al.
Publicado: (2017)

Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial
por: Postma, Douwe F., et al.
Publicado: (2019)

The effect of air temperature on hospital admission of adults with community acquired pneumonia in Baotou, China
por: Guo, Wenfang, et al.
Publicado: (2021)

Macrolide-Resistant Mycoplasma pneumoniae, United States
por: Zheng, Xiaotian, et al.
Publicado: (2015)

Macrolides Decrease the Proinflammatory Activity of Macrolide-Resistant Streptococcus pneumoniae
por: Domon, Hisanori, et al.
Publicado: (2023)

Identification of Bacterial and Viral Codetections With Mycoplasma pneumoniae Using the TaqMan Array Card in Patients Hospitalized With Community-Acquired Pneumonia
por: Diaz, Maureen H., et al.
Publicado: (2016)

Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Hospital-Acquired Pneumonia among Inpatients via the Emergency Department: A Propensity-Score Matched Analysis
por: Min, Jin-young, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_omft35a72ca4eth181cefaugc2